← Back to guidelines
Pediatrics3 papers

Siegler Brewer Carey syndrome

Last edited: 4/16/2026

Overview

Carey-Fineman-Ziter (CFZ) syndrome is a rare genetic disorder characterized by multiple congenital anomalies including cleft palate, micrognathia, Möbius sequence, developmental delay, myopathy, hydronephrosis, and bilateral clubfeet 1.

Diagnosis

  • Key diagnostic criteria: cleft palate, micrognathia, Möbius sequence, developmental delay, myopathy, hydronephrosis, bilateral clubfeet 1.
  • Recommended imaging: cranial MRI to assess for pontine hypoplasia, a novel finding in this syndrome 1.
  • Management

  • No specific first-line treatments mentioned; management is multidisciplinary focusing on symptomatic care 1.
  • Address developmental delays with early intervention programs 1.
  • Manage myopathy and musculoskeletal issues with physical therapy and supportive devices 1.
  • Monitor and treat hydronephrosis with pediatric urology consultation 1.
  • Special Populations

  • Pediatrics: Early intervention and multidisciplinary care are crucial 1.
  • Comorbidities: Specific management strategies for comorbidities like hydronephrosis require specialist input 1.
  • Key Recommendations

  • Perform cranial MRI to evaluate for pontine hypoplasia in patients suspected of having CFZ syndrome (Evidence: Moderate) 1.
  • Implement early intervention programs to address developmental delays (Evidence: Expert opinion) 1.
  • Seek pediatric urology consultation for management of hydronephrosis (Evidence: Expert opinion) 1.
  • References

    1 Maheshwari A, Calhoun DA, Lacson A, Pereda L, Nelson RM, Saste MD et al.. Pontine hypoplasia in Carey-Fineman-Ziter (CFZ) syndrome. American journal of medical genetics. Part A 2004. link

    Original source

    1. [1]
      Pontine hypoplasia in Carey-Fineman-Ziter (CFZ) syndrome.Maheshwari A, Calhoun DA, Lacson A, Pereda L, Nelson RM, Saste MD et al. American journal of medical genetics. Part A (2004)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG